KPWS
GMAB icon

Kestra Private Wealth Services’s Genmab GMAB Stock Holding History

Kestra Private Wealth Services’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,061
Closed -$833K – 1815
2025
Q4 		$833K Buy
+27,061
New +$843K 0.01% 889

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Kestra Private Wealth Services's GMAB Position: Q1 2026 in Review

Kestra Private Wealth Services sold out of Genmab (GMAB) in Q1 2026, closing a stake of 27,061 shares — an estimated $833K sold.

Kestra Private Wealth Services first reported a position in GMAB in Q4 2025 and held it in 1 quarter. The position peaked at $833K in Q4 2025. 274 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Kestra Private Wealth Services reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Kestra Private Wealth Services sold 27,061 Genmab shares in Q1 2026, an estimated $833K.
  • Kestra Private Wealth Services first reported a position in Genmab in Q4 2025 and held it in 1 quarter.
  • Kestra Private Wealth Services's Genmab position peaked at $833K in Q4 2025.
  • 274 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.